NEW YORK, Feb. 11 (GenomeWeb News) - Epoch Biosciences of Bothell, Wash., today announced a licensing agreement with Celera Diagnostics.
Epoch will license its MGB and Eclipse Dark Quencher technologies into Celera Diagnostics' products for selected infectious diseases, the company said in a statement.
The license allows Celera Diagnostics to manufacture, sell and distribute TaqMan probes that utilize Epoch's minor groove binder and quencher in selected products. Under the license agreement, Epoch will receive license fees and royalties on sales of such licensed products to end users. Additional terms of the agreement were not disclosed.
Celera Diagnostics is a joint venture between the Celera Genomics and Applied Biosystems of Applera.